https://news.emory.edu/tags/expert/suresh_ramalingam/index.htmlNationally recognized for his research, Winship Cancer Institute's Dr. Suresh Ramalingam has developed individualized therapies for patients with small cell and non-small cell lung cancer.Wed, 05 Jan 2022 02:42:38 -0500https://news.emory.edu//stories/2014/11/hspub_every_cancer_is_personal/campus.htmlhttps://news.emory.edu//stories/2014/11/hspub_every_cancer_is_personal/campus.htmlWinship Cancer Institute clinicians and scientists work with their research partners across campus and the country to design, develop, and test new, personalized treatment regimens. Increasingly those regimens are specific to each patient.Fri, 14 Nov 2014 01:00:00 -0500https://news.emory.edu//stories/2013/06/asco_ramalingam_hsp90/index.htmlhttps://news.emory.edu//stories/2013/06/asco_ramalingam_hsp90/index.htmlPhase II clinical trial data presented at the 2013 ASCO meeting suggests the hsp90 inhibitor ganetespib in combination with docetaxel can be an effective second-line therapy for advanced lung cancer. Mon, 03 Jun 2013 01:00:00 -0400https://news.emory.edu//stories/2012/09/hspub_phase1_trials_winship/campus.htmlhttps://news.emory.edu//stories/2012/09/hspub_phase1_trials_winship/campus.htmlThe phase 1 unit at the Winship Cancer Institute evaluates drugs given to cancer patients for the first time, advancing cures and bringing hope.Thu, 27 Sep 2012 01:00:00 -0400https://news.emory.edu//stories/2012/06/lung_cancer_breath_test/index.htmlhttps://news.emory.edu//stories/2012/06/lung_cancer_breath_test/index.htmlA breath test to detect established lung cancer showed promising results in a study by researchers at Winship Cancer Institute of Emory University and Georgia Institute of Technology.Mon, 04 Jun 2012 20:15:00 -0400